Similarly, OPN is upregulated in EGFR-TKI-resistant NSCLC cells, thereby activating the PI3K/Akt pathway, leading to downregulation of EGFR-TKI-induced apoptosis while augmenting EMT [42]. Here, EGFR is linked to non-small cell lung carcinoma.